Infusion 51a is a modern impact investment fund. We take positions in public and private oncology companies facing development obstacles and then work to improve their prospects through a variety of tactics. Our team's unusual combination of financial acumen and operational talent in target industries promises favorable risk-return dynamics for our investors. Our current focus is on life sciences and medical technology in oncology, with an emphasis on precision medicine. Our Value Creation Proposal: -World-class consulting -Strengthening of management teams -Restructuring of the composition of the Board of Directors -Shaping relationships with shareholders -Optimization of capital structures -Improved branding, marketing, and media relations. -Assistance with corporate legal and intellectual property needs